Smart Insulin Pens Market By Type (First Generation Pens, Second Generation Pens), By Usability (Prefilled, Reusable), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2020-2030
The global smart insulin pens market was valued at $94.8 million in 2020, and is estimated to reach $298.9 million by 2030, growing at a CAGR of 12.2% from 2021 to 2030.
Smart insulin pens are used for external insulin delivery thus offering an easy to carry solution for diabetes management. Different kinds of smart insulin pens and associated devices, such as smart pen caps, are in the market, and smart insulin pens with connectivity are defined as those with built-in interface technology.
The demand for insulin pens has increased considerably in the recent years owing to surge in incidence of diabetic patients coupled with the cost-effective nature of insulin pens as compared to insulin pumps. In addition, their simple functioning and accuracy related to insulin dosing further stimulates their demand. However, there are certain disadvantages associated with the use of insulin pen such as two types of insulin cannot be mixed in an insulin pen, thus increasing the frequency of injections needed. This in turn impedes the market growth.
The smart insulin pens market is segmented on the basis of type, usability, end user, and region. By type, the market is classified into first generation and second-generation insulin pens. The second-generation insulin pens are further bifurcated into Bluetooth-enabled and USB-connected insulin pens. By usability, it is divided into pre-filled and reusable insulin pumps. According to the end user, the market is classified into hospitals & clinics, ambulatory surgical centers, and home care settings. By region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
The key players that operate in the smart insulin pens market include Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk, Pendiq and Sanofi.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smart insulin pens market analysis from 2020 to 2030 to identify the prevailing smart insulin pens market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the smart insulin pens market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global smart insulin pens market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Home Care Settings
By Type
First Generation Pens
Second Generation Pens
By Usability
Prefilled
Reusable
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Emperra GmbH
Jiangsu Deflu Medical Device Co. Ltd.
Medtronic plc
Novo Nordisk
Pendiq
Sanofi
Berlin-Chemie
Bigfoot Biomedical
Digital Medics Pty Ltd.
Eli Lilly and Company
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: SMART INSULIN PENS MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 First Generation Pens
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Second Generation Pens
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: SMART INSULIN PENS MARKET, BY USABILITY
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Prefilled
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Reusable
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- CHAPTER 6: SMART INSULIN PENS MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Home Care Settings
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: SMART INSULIN PENS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Usability
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Usability
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Usability
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Usability
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Usability
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Usability
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Usability
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Usability
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Usability
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Usability
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Usability
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Usability
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Usability
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Usability
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Usability
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Usability
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 Rest of Asia-Pacific
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Usability
- 7.4.5.5.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Usability
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Usability
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Usability
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Usability
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Usability
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Emperra GmbH
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Jiangsu Deflu Medical Device Co. Ltd.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Medtronic plc
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Novo Nordisk
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Pendiq
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Sanofi
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Berlin-Chemie
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Bigfoot Biomedical
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Digital Medics Pty Ltd.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Eli Lilly and Company
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 2. SMART INSULIN PENS MARKET SIZE, FOR FIRST GENERATION PENS, BY REGION, 2020-2030 ($MILLION)
- TABLE 3. SMART INSULIN PENS MARKET FOR FIRST GENERATION PENS, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 4. SMART INSULIN PENS MARKET SIZE, FOR SECOND GENERATION PENS, BY REGION, 2020-2030 ($MILLION)
- TABLE 5. SMART INSULIN PENS MARKET FOR SECOND GENERATION PENS, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 6. GLOBAL SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 7. SMART INSULIN PENS MARKET SIZE, FOR PREFILLED, BY REGION, 2020-2030 ($MILLION)
- TABLE 8. SMART INSULIN PENS MARKET FOR PREFILLED, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 9. SMART INSULIN PENS MARKET SIZE, FOR REUSABLE, BY REGION, 2020-2030 ($MILLION)
- TABLE 10. SMART INSULIN PENS MARKET FOR REUSABLE, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 11. GLOBAL SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 12. SMART INSULIN PENS MARKET SIZE, FOR HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
- TABLE 13. SMART INSULIN PENS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 14. SMART INSULIN PENS MARKET SIZE, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
- TABLE 15. SMART INSULIN PENS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 16. SMART INSULIN PENS MARKET SIZE, FOR HOME CARE SETTINGS, BY REGION, 2020-2030 ($MILLION)
- TABLE 17. SMART INSULIN PENS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 18. SMART INSULIN PENS MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 19. NORTH AMERICA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 20. NORTH AMERICA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 21. NORTH AMERICA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 22. NORTH AMERICA SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 23. U.S. SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 24. U.S. SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 25. U.S. SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 26. CANADA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 27. CANADA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 28. CANADA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 29. MEXICO SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 30. MEXICO SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 31. MEXICO SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 32. EUROPE SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 33. EUROPE SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 34. EUROPE SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 35. EUROPE SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 36. GERMANY SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 37. GERMANY SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 38. GERMANY SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 39. FRANCE SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 40. FRANCE SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 41. FRANCE SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 42. U.K. SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 43. U.K. SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 44. U.K. SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 45. ITALY SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 46. ITALY SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 47. ITALY SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 48. SPAIN SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 49. SPAIN SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 50. SPAIN SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 51. REST OF EUROPE SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 52. REST OF EUROPE SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 53. REST OF EUROPE SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 54. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 55. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 56. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 57. ASIA-PACIFIC SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 58. JAPAN SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 59. JAPAN SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 60. JAPAN SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 61. CHINA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 62. CHINA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 63. CHINA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 64. INDIA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 65. INDIA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 66. INDIA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 67. AUSTRALIA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 68. AUSTRALIA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 69. AUSTRALIA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 70. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 72. REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 73. LAMEA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 74. LAMEA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 75. LAMEA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 76. LAMEA SMART INSULIN PENS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
- TABLE 77. BRAZIL SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 78. BRAZIL SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 79. BRAZIL SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 80. SAUDI ARABIA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 81. SAUDI ARABIA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 82. SAUDI ARABIA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 83. SOUTH AFRICA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 84. SOUTH AFRICA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 85. SOUTH AFRICA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 86. REST OF LAMEA SMART INSULIN PENS MARKET, BY TYPE, 2020-2030 ($MILLION)
- TABLE 87. REST OF LAMEA SMART INSULIN PENS MARKET, BY USABILITY, 2020-2030 ($MILLION)
- TABLE 88. REST OF LAMEA SMART INSULIN PENS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 89.EMPERRA GMBH: COMPANY SNAPSHOT
- TABLE 90.EMPERRA GMBH: OPERATING SEGMENTS
- TABLE 91.EMPERRA GMBH: PRODUCT PORTFOLIO
- TABLE 92.EMPERRA GMBH: NET SALES,
- TABLE 93.EMPERRA GMBH: KEY STRATERGIES
- TABLE 94.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: COMPANY SNAPSHOT
- TABLE 95.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: OPERATING SEGMENTS
- TABLE 96.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: PRODUCT PORTFOLIO
- TABLE 97.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: NET SALES,
- TABLE 98.JIANGSU DEFLU MEDICAL DEVICE CO. LTD.: KEY STRATERGIES
- TABLE 99.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 100.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 101.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 102.MEDTRONIC PLC: NET SALES,
- TABLE 103.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 104.NOVO NORDISK: COMPANY SNAPSHOT
- TABLE 105.NOVO NORDISK: OPERATING SEGMENTS
- TABLE 106.NOVO NORDISK: PRODUCT PORTFOLIO
- TABLE 107.NOVO NORDISK: NET SALES,
- TABLE 108.NOVO NORDISK: KEY STRATERGIES
- TABLE 109.PENDIQ: COMPANY SNAPSHOT
- TABLE 110.PENDIQ: OPERATING SEGMENTS
- TABLE 111.PENDIQ: PRODUCT PORTFOLIO
- TABLE 112.PENDIQ: NET SALES,
- TABLE 113.PENDIQ: KEY STRATERGIES
- TABLE 114.SANOFI: COMPANY SNAPSHOT
- TABLE 115.SANOFI: OPERATING SEGMENTS
- TABLE 116.SANOFI: PRODUCT PORTFOLIO
- TABLE 117.SANOFI: NET SALES,
- TABLE 118.SANOFI: KEY STRATERGIES
- TABLE 119.BERLIN-CHEMIE: COMPANY SNAPSHOT
- TABLE 120.BERLIN-CHEMIE: OPERATING SEGMENTS
- TABLE 121.BERLIN-CHEMIE: PRODUCT PORTFOLIO
- TABLE 122.BERLIN-CHEMIE: NET SALES,
- TABLE 123.BERLIN-CHEMIE: KEY STRATERGIES
- TABLE 124.BIGFOOT BIOMEDICAL: COMPANY SNAPSHOT
- TABLE 125.BIGFOOT BIOMEDICAL: OPERATING SEGMENTS
- TABLE 126.BIGFOOT BIOMEDICAL: PRODUCT PORTFOLIO
- TABLE 127.BIGFOOT BIOMEDICAL: NET SALES,
- TABLE 128.BIGFOOT BIOMEDICAL: KEY STRATERGIES
- TABLE 129.DIGITAL MEDICS PTY LTD.: COMPANY SNAPSHOT
- TABLE 130.DIGITAL MEDICS PTY LTD.: OPERATING SEGMENTS
- TABLE 131.DIGITAL MEDICS PTY LTD.: PRODUCT PORTFOLIO
- TABLE 132.DIGITAL MEDICS PTY LTD.: NET SALES,
- TABLE 133.DIGITAL MEDICS PTY LTD.: KEY STRATERGIES
- TABLE 134.ELI LILLY AND COMPANY: COMPANY SNAPSHOT
- TABLE 135.ELI LILLY AND COMPANY: OPERATING SEGMENTS
- TABLE 136.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
- TABLE 137.ELI LILLY AND COMPANY: NET SALES,
- TABLE 138.ELI LILLY AND COMPANY: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.SMART INSULIN PENS MARKET SEGMENTATION
- FIGURE 2.SMART INSULIN PENS MARKET,2020-2030
- FIGURE 3.SMART INSULIN PENS MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.SMART INSULIN PENS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.SMART INSULIN PENS MARKET,BY TYPE,2020(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF FIRST GENERATION PENS SMART INSULIN PENS MARKET,2020-2030(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SECOND GENERATION PENS SMART INSULIN PENS MARKET,2020-2030(%)
- FIGURE 15.SMART INSULIN PENS MARKET,BY USABILITY,2020(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PREFILLED SMART INSULIN PENS MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF REUSABLE SMART INSULIN PENS MARKET,2020-2030(%)
- FIGURE 18.SMART INSULIN PENS MARKET,BY END USER,2020(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS SMART INSULIN PENS MARKET,2020-2030(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS SMART INSULIN PENS MARKET,2020-2030(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOME CARE SETTINGS SMART INSULIN PENS MARKET,2020-2030(%)
- FIGURE 22.SMART INSULIN PENS MARKET BY REGION,2020
- FIGURE 23.U.S. SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 24.CANADA SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 25.MEXICO SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 26.GERMANY SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 27.FRANCE SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 28.U.K. SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 29.ITALY SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 30.SPAIN SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 31.REST OF EUROPE SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 32.JAPAN SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 33.CHINA SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 34.INDIA SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 35.AUSTRALIA SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 36.REST OF ASIA-PACIFIC SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 37.BRAZIL SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 38.SAUDI ARABIA SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 39.SOUTH AFRICA SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 40.REST OF LAMEA SMART INSULIN PENS MARKET,2020-2030($MILLION)
- FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 45.COMPETITIVE DASHBOARD
- FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 47.EMPERRA GMBH.: NET SALES ,($MILLION)
- FIGURE 48.JIANGSU DEFLU MEDICAL DEVICE CO. LTD..: NET SALES ,($MILLION)
- FIGURE 49.MEDTRONIC PLC.: NET SALES ,($MILLION)
- FIGURE 50.NOVO NORDISK.: NET SALES ,($MILLION)
- FIGURE 51.PENDIQ.: NET SALES ,($MILLION)
- FIGURE 52.SANOFI.: NET SALES ,($MILLION)
- FIGURE 53.BERLIN-CHEMIE.: NET SALES ,($MILLION)
- FIGURE 54.BIGFOOT BIOMEDICAL.: NET SALES ,($MILLION)
- FIGURE 55.DIGITAL MEDICS PTY LTD..: NET SALES ,($MILLION)
- FIGURE 56.ELI LILLY AND COMPANY.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook